Sarepta Therapeutics | SRPT - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 16.33M 28.24M 2026-09
Agios Pharmaceuticals USD 19.93M 3.58M 2026-09
Alnylam Pharmaceuticals USD 135.4M 27.38M 2026-09
Amgen USD 20.83B 17.97B 2026-09
BioCryst Pharmaceuticals USD 14.58M 3.12M 2026-09
Biogen USD 430.3M 26.4M 2026-09
BioMarin Pharmaceutical USD 946.11M 32.44M 2026-09
Capricor Therapeutics 3.08M 848.23K 2026-06
Daiichi Sankyo JPY 612.24B 73.19B 2026-09
Eli Lilly USD 5.79B 319M 2026-09
Gilead Sciences USD 934M 260M 2026-09
Incyte USD 235.37M 1.16B 2026-09
Insmed USD 84.3M 9.75M 2026-09
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Moderna USD 167M 6M 2026-06
Nektar Therapeutics USD 10.03M 744K 2026-03
Neurocrine Biosciences USD 754.1M 612.1M 2026-09
Novavax USD 24.94M 2.01M 2026-09
Pfizer USD 4.07B 511M 2026-09
PTC Therapeutics USD 41.59M 1.14M 2026-09
Regeneron Pharmaceuticals USD 1.14B 19M 2026-09
Roche Holding CHF 5.54B 237M 2026-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 24.55B 957M 2026-09
Sarepta Therapeutics USD 45.7M 5.28M 2026-09
Tectonic Therapeutic USD 1.68M 877K 2026-06
Ultragenyx Pharmaceutical USD 45M 6M 2026-09
Vertex Pharmaceuticals USD 3.71B 99.2M 2026-09